APA-viite

Gatt, M. E., Takada, K., Mani, M., Lerner, M., Pick, M., Hideshima, T., . . . Carrasco, D. R. (2013). TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.

Chicago-tyylinen lähdeviittaus

Gatt, Moshe E., et al. TRIM13 (RFP2) Downregulation Decreases Tumour Cell Growth in Multiple Myeloma Through Inhibition of NF Kappa B Pathway and Proteasome Activity. 2013.

MLA-viite

Gatt, Moshe E., et al. TRIM13 (RFP2) Downregulation Decreases Tumour Cell Growth in Multiple Myeloma Through Inhibition of NF Kappa B Pathway and Proteasome Activity. 2013.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.